diabetesincontrol.com
Cardiovascular Outcomes in Diabetes: New Evidence From 2025 Trials
Discover groundbreaking 2025 trials reshaping cardiovascular outcomes in diabetes, highlighting new therapies and holistic care strategies.
How GLP-1 Drugs Like Ozempic and Mounjaro Are Redefining Diabetes Care
Discover how GLP-1 drugs like Ozempic and Mounjaro are transforming diabetes care by enhancing glycemic control and reducing cardiovascular risks.
Weight Loss and Diabetes Management: Why New Drugs Are Changing the Standard of Care
Discover how new drugs are transforming weight loss and diabetes management, setting new standards in care and improving patient outcomes.
From Tirzepatide to Semaglutide: How New Therapies Are Changing Diabetes Care
Discover how Tirzepatide and Semaglutide are revolutionizing diabetes care by enhancing glycemic control, weight loss, and cardiovascular health.
Latest ADA Guidelines for Type 2 Diabetes Management: Key Updates for Clinicians
Explore the latest ADA Guidelines for Type 2 Diabetes, highlighting personalized care, cardiovascular risk management, and new medication options for clinicians.
Can Early Remission Become the New Standard in Type 2 Diabetes?
Discover how early remission could redefine type 2 diabetes care, shifting from symptom management to potential disease reversal.
The Hidden Cardiovascular Risks in Type 2 Diabetes: What Every Provider Should Watch For
Explore the hidden cardiovascular risks in type 2 diabetes and learn essential strategies for healthcare providers to improve patient outcomes.